Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Imatinib'

Imatinib published presentations and documents on DocSlides.

Impact of Imatinib interruption & duration of prior Hyd
Impact of Imatinib interruption & duration of prior Hyd
by pamella-moone
Raafat. R. Abdel-. Malek. , MD, FRCR. Ass. Prof ...
Imatinib
Imatinib
by phoebe-click
Resistance. Geoffrey L. Uy, M.D.. Associate Prof...
Imatinib Resistance Geoffrey L. Uy, M.D.
Imatinib Resistance Geoffrey L. Uy, M.D.
by karlyn-bohler
Associate Professor . of Medicine. Division of On...
Impact of Imatinib interruption & duration of prior Hydroxyurea on treatment outcome in CML pat
Impact of Imatinib interruption & duration of prior Hydroxyurea on treatment outcome in CML pat
by hadly
Raafat. R. Abdel-. Malek. , MD, FRCR. Ass. Prof C...
ETV1 is a lineage survival factor that cooperates with KIT
ETV1 is a lineage survival factor that cooperates with KIT
by test
stromal. tumors. Introduction. Tim Butler. March...
Gastrointestinal Stromal Tumors
Gastrointestinal Stromal Tumors
by tawny-fly
Definition of Gastrointestinal Stromal Tumor . th...
Modeling Imatinib-Treated Chronic Myeloid Leukemia
Modeling Imatinib-Treated Chronic Myeloid Leukemia
by phoebe-click
Cara Peters. cpeters3@math.umd.edu. Advisor: Dr. ...
ADVANCES IN THERAPY FOR SARCOMA AND GIST
ADVANCES IN THERAPY FOR SARCOMA AND GIST
by ellena-manuel
Angela . Cioffi. , MD. Sarcoma Research Program c...
GREETING BUENOS DÍAS GOOD MORNING
GREETING BUENOS DÍAS GOOD MORNING
by escapistlego
BONJOUR. Tolerance of . Imatinib. . Dasatinib. ...
Overview of CML & Recent Advances
Overview of CML & Recent Advances
by stella
I. ntroduction. CML is a clonal myeloproliferative...
S1 TableRisk classification according to Armed Forces Institute of Pa
S1 TableRisk classification according to Armed Forces Institute of Pa
by finley
A FIP risk criteria 3 ears of imatinib (n= 31) 5 Y...
SCIENTIFIC DISCUSSION 1 Introduction The scope of this Type II varia
SCIENTIFIC DISCUSSION 1 Introduction The scope of this Type II varia
by evelyn
Metastasis of DFSP is rare, occurring in approxima...
Treatment of Imatinib -resistant GIST
Treatment of Imatinib -resistant GIST
by beatrice
: . The Next Generation. Dr. Michael Heinrich, M....
Anticancer Therapy:
Anticancer Therapy:
by stefany-barnette
Kinase. Inhibitors. Charles Harrell. Outline of ...
Philadephia
Philadephia
by danika-pritchard
chromosomal positive acute lymphoblastic leukemi...
Clinical Considerations in
Clinical Considerations in
by faustina-dinatale
Evidence-based Management . of GIST. Program Goal...
Chronic
Chronic
by briana-ranney
M. yeloid Leukemia. Amer Rassam, M.D.. Learning O...
OHSU Updates in Hematology
OHSU Updates in Hematology
by calandra-battersby
and. Breast Cancer Conference. CML . ASH Update. ...
Prof Giovanni Brandi
Prof Giovanni Brandi
by liane-varnes
. University. of Bologna . Advances. in . c...
Jon Trent, MD, PhD Professor of Medicine
Jon Trent, MD, PhD Professor of Medicine
by jane-oiler
Sarcoma . Medical Oncology. The University of . M...
Chronic M yeloid Leukemia
Chronic M yeloid Leukemia
by eliza
Amer Rassam, M.D.. Learning Objectives. Myeloproli...
La LAL del adulto tiene mal pronóstico
La LAL del adulto tiene mal pronóstico
by walsh
PETHEMA LAL infantil. PETHEMA LAL Adulto. 15%. 25%...
Proceedings of UCLA HealthVOLUME 22201CLINICAL VIGNETTE
Proceedings of UCLA HealthVOLUME 22201CLINICAL VIGNETTE
by tracy
Dermatofibrosarcoma protuberans Fukai Leo Chuang, ...